Yihan Li
Stock Analyst at Barclays
(2.88)
# 2,686
Out of 4,501 analysts
41
Total ratings
75%
Success rate
14.3%
Average return
Main Sectors:
Stocks Rated by Yihan Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | $162.70 | +4.49% | 13 | Jul 1, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $86 → $65 | $45.29 | +43.29% | 2 | May 11, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 155.00 | $172.85 | -10.33% | 21 | Dec 8, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 375.00 | $320.30 | +17.08% | 2 | Nov 28, 2025 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 275.00 | $336.60 | -18.30% | 3 | Oct 24, 2025 |
Ipsen S.A.
Jul 1, 2026
Maintained: Hold
Price Target: €170.00
Current: $162.70
Upside: +4.49%
Zealand Pharma A/S
May 11, 2026
Maintained: Buy
Price Target: $86 → $65
Current: $45.29
Upside: +43.29%
Galderma Group AG
Dec 8, 2025
Maintained: Buy
Price Target: CHF 155.00
Current: $172.85
Upside: -10.33%
Novo Nordisk A/S
Nov 28, 2025
Maintained: Hold
Price Target: kr 375.00
Current: $320.30
Upside: +17.08%
Roche Holding AG
Oct 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $336.60
Upside: -18.30%